Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 24 | $16,104,483 |
Sells | 4 | $102,634 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
15 Apr 2024 19:21 | OCX | Oncocyte Corp | BROADWOOD PARTNERS, L.P. | 10% | 11 Apr 2024 | Purchase | 2,420,000 | 2.9164 | 7,057,688 | D |
15 Apr 2024 06:04 | OCX | Oncocyte Corp | RIGGS JOSH | CEO and President | 11 Apr 2024 | Purchase | 3,390 | 2.95 | 10,000 | D |
15 Apr 2024 06:02 | OCX | Oncocyte Corp | ARNO ANDREW | Director | 11 Apr 2024 | Purchase | 33,898 | 2.95 | 99,999 | D |
15 Jun 2023 20:13 | OCX | Oncocyte Corp | KINGSLEY ALFRED D | Director | 14 Jun 2023 | Purchase | 30,000 | 0.2149 | 6,447 | D |
07 Apr 2023 17:12 | OCX | Oncocyte Corp | PURA VIDA INVESTMENTS, LLC | 10% | 05 Apr 2023 | Purchase | 663,000 | 0.3017 | 200,027 | I |
05 Apr 2023 21:35 | OCX | Oncocyte Corp | BROADWOOD PARTNERS, L.P. | 10% | 03 Apr 2023 | Purchase | 26,827,638 | 0.3017 | 8,093,898 | D |
28 Dec 2022 16:05 | OCX | Oncocyte Corp | ARNO ANDREW | Director | 23 Dec 2022 | Purchase | 250,000 | 0.3515 | 87,875 | D |
28 Dec 2022 16:05 | OCX | Oncocyte Corp | GUTFREUND JOHN PETER | Director | 23 Dec 2022 | Purchase | 75,000 | 0.3297 | 24,728 | I |
27 Dec 2022 18:47 | OCX | Oncocyte Corp | KINGSLEY ALFRED D | Director | 22 Dec 2022 | Purchase | 25,000 | 0.285 | 7,125 | D |
19 Aug 2022 08:00 | OCX | Oncocyte Corp | LAST ANDREW J. | Director | 17 Aug 2022 | Purchase | 20,000 | 0.87 | 17,400 | D |
19 Aug 2022 08:00 | OCX | Oncocyte Corp | ARNO ANDREW | Director | 17 Aug 2022 | Purchase | 7,500 | 0.9 | 6,750 | I |
19 Aug 2022 08:00 | OCX | Oncocyte Corp | ARNO ANDREW | Director | 17 Aug 2022 | Purchase | 7,500 | 0.9 | 6,750 | I |
18 Aug 2022 16:05 | OCX | Oncocyte Corp | ANDREWS RONALD ASBURY | President & CEO | 16 Aug 2022 | Purchase | 40,000 | 0.96 | 38,400 | D |
17 Aug 2022 20:20 | OCX | Oncocyte Corp | KINGSLEY ALFRED D | Director | 15 Aug 2022 | Purchase | 5,000 | 0.97 | 4,850 | D |
17 Aug 2022 20:20 | OCX | Oncocyte Corp | KINGSLEY ALFRED D | Director | 15 Aug 2022 | Purchase | 5,000 | 0.97 | 4,850 | D |
17 Aug 2022 20:19 | OCX | Oncocyte Corp | GUTFREUND JOHN PETER | Director | 15 Aug 2022 | Purchase | 25,000 | 0.93 | 23,250 | I |
17 Aug 2022 20:18 | OCX | Oncocyte Corp | GRIFFITH MELINDA | Director | 16 Aug 2022 | Purchase | 10,000 | 1 | 10,000 | D |
17 Aug 2022 20:17 | OCX | Oncocyte Corp | CARTER JENNIFER L. | Director | 16 Aug 2022 | Purchase | 10,500 | 0.95 | 9,975 | D |
17 Aug 2022 20:15 | OCX | Oncocyte Corp | ARNO ANDREW | Director | 16 Aug 2022 | Purchase | 115,523 | 0.97 | 112,057 | D |
17 Aug 2022 20:15 | OCX | Oncocyte Corp | ARNO ANDREW | Director | 15 Aug 2022 | Purchase | 34,477 | 0.93 | 32,064 | D |
28 Jun 2022 19:48 | OCX | Oncocyte Corp | PURA VIDA INVESTMENTS, LLC | 10% | 24 Jun 2022 | Sale | 40,464 | 1.0269 | 41,552 | I |
28 Jun 2022 19:48 | OCX | Oncocyte Corp | PURA VIDA INVESTMENTS, LLC | 10% | 24 Jun 2022 | Sale | 12,517 | 1.0514 | 13,160 | I |
28 Jun 2022 19:48 | OCX | Oncocyte Corp | PURA VIDA INVESTMENTS, LLC | 10% | 24 Jun 2022 | Sale | 35,441 | 1.0269 | 36,394 | I |
28 Jun 2022 19:48 | OCX | Oncocyte Corp | PURA VIDA INVESTMENTS, LLC | 10% | 24 Jun 2022 | Sale | 10,964 | 1.0514 | 11,528 | I |
28 Jun 2022 19:46 | OCX | Oncocyte Corp | PURA VIDA INVESTMENTS, LLC | 10% | 14 Apr 2022 | Purchase A | 57,630 | 1.26 | 72,614 | I |
28 Jun 2022 19:46 | OCX | Oncocyte Corp | PURA VIDA INVESTMENTS, LLC | 10% | 14 Apr 2022 | Purchase A | 19,210 | 1.227 | 23,571 | I |
28 Jun 2022 19:46 | OCX | Oncocyte Corp | PURA VIDA INVESTMENTS, LLC | 10% | 14 Apr 2022 | Purchase A | 92,370 | 1.26 | 116,386 | I |
28 Jun 2022 19:46 | OCX | Oncocyte Corp | PURA VIDA INVESTMENTS, LLC | 10% | 14 Apr 2022 | Purchase A | 30,790 | 1.227 | 37,779 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)